Sage Therapeutics
- Pharmaceutical Preparations
- Cambridge, Massachusetts
Compensation history
Top executives at Sage Therapeutics received an average of $4M per person in annual compensation from 2013 to 2021.
Average pay of disclosed executives at Sage Therapeutics
By year
- 2020
JJ$5MJeffrey M. JonasChief Innovation Officer, former President and Chief Executive OfficerMC$5MMichael CloonanChief Operating OfficerAC$2MAnne Marie CookSenior Vice President, General CounselAR$2MAlbert J. RobichaudChief Scientific OfficerKI$2MKimi IguchiChief Financial Officer and TreasurerBG$826KBarry E. GreeneChief Executive Officer and President- 2019
JJ$10MJeffrey M. JonasPresident and Chief Executive OfficerMC$5MMichael CloonanChief Business OfficerSK$4MStephen J. KanesChief Medical OfficerAC$4MAnne Marie CookSenior Vice President, General CounselAR$4MAlbert J. RobichaudChief Scientific OfficerKI$4MKimi IguchiChief Financial Officer and Treasurer
Executives
We found eight executives who work or worked at Sage Therapeutics.
Barry Greene
Sage Therapeutics
Chief Executive Officer
Kimi Iguchi
Sage Therapeutics
Chief Financial Officer
Christopher Benecchi
Sage Therapeutics
Chief Commercial Officer
Jeffrey Jonas
Sage Therapeutics
Chief Innovation Officer
Albert Robichaud
Sage Therapeutics
Chief Scientific Officer
Michael Cloonan
Sage Therapeutics
Chief Operating Officer
Anne Cook
Sage Therapeutics
General Counsel
Stephen Kanes
Sage Therapeutics
Chief Medical Officer
News
Sage Therapeutics CEO Barry Greene's 2021 pay jumps 469% to $59M
April 28, 2022
Sage Therapeutics CEO Jeffrey Jonas' 2020 pay falls 53% to $4.7M
April 29, 2021
Sage Therapeutics CEO Jeffrey Jonas' 2019 pay rises 1% to $9.9M
April 29, 2020
Sage Therapeutics CEO Jeffrey Jonas' 2018 pay jumps 71% to $9.8M
April 25, 2019
About Sage Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address215 First Street, Cambridge, Massachusetts 02142
- Phone617-299-8380
- Fiscal year endDecember 31
Source: SEC filings on April 28, 2022, April 29, 2021, April 27, 2018, and April 17, 2015.